Microbiota of the small intestine in patients with COVID-19
نویسندگان
چکیده
To date, the study of relationship between intestinal microbiome and COVID-19 infection remains a topical issue. As is known, gastrointestinal tract entrance gate for SARS-CoV2 infection, prevalence manifestations reaches 17,6%. The conducted studies testify in favor changes composition microflora patients with compared without respiratory their influence on course prognosis disease being studied.
منابع مشابه
Patients with Down syndrome in the coronavirus Pandemic (Covid 19)
Background and purpose: Coronavirus (QUID-19) is an infectious disease of the respiratory system that has been identified by the World Health Organization as an epidemic. Patients with Down syndrome are more likely to develop Quidd-19 disease with more severe complications due to the underlying comorbidities they have. The aim of this study was to evaluate the complications of Covid-19 disease...
متن کاملPrevalence of Psychological Disorders in Patients with COVID-19 Syndrome
A B S T R A C T The coronavirus 2019 first broke out on December 17, 2019 in Wuhan, China, and on March 11, 2020, it was announced as a worldwide pandemic by the World Health Organization. Despite nutritious diets and promising vaccines, health tips such as wearing a mask, social distancing, home quarantine, and not traveling are still the best ways to control the spread of COVID-19.While the ...
متن کاملPredictors of Corona Anxiety in patients with COVID-19
Introduction: As a worldwide pandemic, COVID-19 has led to low quality of life for patients and many psychological disorders, particularly among patients with coronavirus. Accordingly, this study aimed at Predictors of Corona Anxiety in patients with COVID-19. Methods: This is a descriptive-analytical study. 119 patients with covid-19 were included in the study using the convenient sampling met...
متن کاملEfficacy of Tocilizumab in Patients with COVID-19
Background and purpose: Tocilizumab (TCZ), a monoclonal antibody against interleukin-6 (IL-6) receptor, is emerged as an alternative treatment for COVID-19 patients with a risk of cytokine storms. This study aimed at investigating the efficacy of TCZ in patients with COVID-19. Materials and methods: In a retrospective observational study, we examined the demographic and clinical characteristi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Experimental & clinical gastroenterology
سال: 2023
ISSN: ['1682-8658']
DOI: https://doi.org/10.31146/1682-8658-ecg-207-11-80-85